@joannamoncrieff@DailyMail I don't agree with the general political view of @DailyMail, but it is right to ask questions about why diagnosis and drug treatment of ADHD is skyrocketing.
If you or one of your loved ones has Alzheimer’s disease, encourage them to wait for placebo-controlled, blinded trial data before they take any medication or supplement. These jokers who rave uncritically about what are probably placebo effects aren’t helpful to people with AD.
🧵Why is mental health disability rising? Here are key reasons rarely discussed in mainstream media:
1️/ For decades we've neglected tackling the social determinants of societal distress, relying instead on medicalisation as a superficial ‘fix’ for downstream harms. This has...
@FeldyJan@NigelKellow@ExCllrRedmond NHS is not always free at the point of service... I have an NHS dentist but pay every time I attend and I also pay for any prescriptions my NHS GP issues.
I would've expelled Antisocial Personality Dsorder from DSM-IV.
Why? Its criteria just describe bad behavior/there's no treatment.
But we had set such high threshold for making any changes, it was grandfathered in.
Unfortunate because confuses distinction between bad & ill.
This piece gives 8 reasons #ADHD rates have more than tripled in last 30 years.
But leaves out 4 most important:
1)DSM/ICD criteria were loosened
2)Pharma marketing to clinicians/parents/teachers/patients
3)Careless fad diagnosis
4)Social media contagion
https://t.co/O4g5S9hHiz
Donanemab is not recommended by NICE for cognitive impairment or dementia caused by Alzheimer's.
This is due to limited benefits and high costs, including monthly infusions and intensive side effect monitoring, therefore it not good use for the taxpayer: https://t.co/A0DumIAowv
Wes Streeting has a very odd belief that a person’s weight is the primary eligibility condition for being employed. Why else is he obsessing about weight loss to get people back to work?